| Followers | 3 |
| Posts | 184 |
| Boards Moderated | 0 |
| Alias Born | 04/06/2014 |
Monday, February 07, 2022 4:02:48 PM
Still heading the wrong direction!
Recent NTRB News
- Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica • GlobeNewswire Inc. • 03/18/2026 11:00:00 AM
- Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica • GlobeNewswire Inc. • 02/17/2026 12:28:27 PM
- Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica • GlobeNewswire Inc. • 02/17/2026 12:00:00 PM
- Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points • GlobeNewswire Inc. • 01/30/2026 12:00:00 PM
- Nutriband CEO Publishes Letter to Shareholders • GlobeNewswire Inc. • 12/31/2025 12:00:00 PM
- Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio • GlobeNewswire Inc. • 12/29/2025 02:00:00 PM
- Nutriband Inc. Signs Letter of Intent with Qvanta Group of Companies to Explore Advanced Technology Solutions for Abuse-Deterrent Pharmaceutical Innovation Strategic Exploration • GlobeNewswire Inc. • 12/18/2025 01:00:00 PM
- Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction • GlobeNewswire Inc. • 12/18/2025 12:00:00 PM
- REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch • GlobeNewswire Inc. • 10/28/2025 03:05:00 PM
- Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch • GlobeNewswire Inc. • 10/28/2025 11:00:00 AM
- Nutriband Co-Founder Gareth Sheridan Returns as CEO • GlobeNewswire Inc. • 10/27/2025 11:00:00 AM
- Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch • GlobeNewswire Inc. • 10/10/2025 11:00:00 AM
- Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology • GlobeNewswire Inc. • 10/08/2025 12:30:00 PM
- Nutriband To Present at the Noble Capital Markets’ Emerging Growth Virtual Equity Conference • GlobeNewswire Inc. • 10/08/2025 10:30:00 AM
- 11 Company Presentations Today at The MicroCap Rodeo Conference • ACCESS Newswire • 09/25/2025 12:00:00 PM
- Nutriband Inc. to Present at the MicroCap Rodeo Conference • GlobeNewswire Inc. • 09/24/2025 08:05:00 PM
- Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl • GlobeNewswire Inc. • 09/10/2025 01:15:00 PM
- Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 • GlobeNewswire Inc. • 09/03/2025 08:01:00 PM
- Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election • GlobeNewswire Inc. • 08/11/2025 09:00:00 AM
- Nutriband Shares Climb After FDA Grants Meeting for Fentanyl Patch • IH Market News • 08/08/2025 02:01:01 PM
- FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch • GlobeNewswire Inc. • 08/08/2025 12:00:00 PM
- Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval • GlobeNewswire Inc. • 07/18/2025 01:15:00 PM
- Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval • GlobeNewswire Inc. • 07/02/2025 12:05:00 PM
- Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index • GlobeNewswire Inc. • 07/01/2025 11:00:00 AM
